
Success isn't always about greatness. It's about consistency. Consistent hard work leads to success. Greatness will come.
Vivian leads Acquis’ Life Sciences practice area. She is a natural explorer, driven by curiosity to uncover creative solutions, chart new paths to sustained success, and lead her clients — particularly in the life sciences — toward an innovative future. A strong advocate for partnership and collaboration, she is dedicated to designing solutions centered on the end user — business or patient. Her focus on understanding individual challenges and processes allows her to deliver customized, impactful results that truly address pain points and needs.
Vivian began her journey in life sciences by designing eCOAs (electronic Clinical Outcome Assessments) for children with autism. It was in this work that she discovered her passion for life sciences and drug development, driving her to pursue a deeper understanding of the industry and its potential to transform patient outcomes.
She is passionate about advancing the life sciences industry through technology and artificial intelligence, recognizing the immense potential these tools have to accelerate drug development, improve patient care, and streamline operations. With extensive experience in driving large-scale transformational programs from concept to execution, Vivian advises life sciences clients to think beyond conventional boundaries, innovate relentlessly, and explore the art-of-the-possible.
Vivian is currently pursuing a Master’s in Healthcare Management at Johns Hopkins University, further deepening her expertise in the healthcare field. Before joining Acquis, she was a consultant with IBM’s Global Business Services, where she developed expertise in managing complex deals, operations strategy, and program management in highly-regulated industries. She holds a Bachelor of Arts in Finance and Marketing from New York University.
Originally from New York City, Vivian now resides in Los Angeles.
Insights by Vivian Lee
ArticleAI Is the Answer, But to What Question?
AI can accelerate life sciences, but only if operating models evolve with it. Five dimensions define whether AI is embedded structurally or stays a pilot.
Read More
ArticleAn Industry in Transition: Early Signals Shaping Life Sciences in 2026
At the end of 2025, we were closely monitoring three trends we believed would shape the next phase of biopharma’s operating model changes in 2026: data pipelines, the role of AI in due diligence, and the next-generation value chain. The J.P. Morgan Healthcare Conference offered the first opportunity to pressure-test those assumptions.
Read More
ArticleResource Management for Clinical Operations
To meet the demands of today’s trials, organizations need more than decentralized headcount tracking. They need a centralized, analytics-enabled resource management capability — one that provides full transparency into bandwidth, talent allocation, and strategic priorities across functions.
Read More
Related Team Members

David KaufmanFounder & Executive Chair 
Abby ShermanPrincipal 
Adam MosenkisPrincipal
